CLINICAL_TRIALS
trial_result
· 2014-09-15
Clinical Trial Update: Study of Treatment Used for Migraine Headaches (MK-0974-076)
Summary
A Merck-sponsored trial evaluating telcagepant (MK-0974) for migraine was terminated. Results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Status: TERMINATED | Results posted: 2014-09-15